Clinical Trial Detail

NCT ID NCT01912625
Title Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

lung non-small cell carcinoma


Carboplatin + Paclitaxel + Trametinib

Age Groups: adult senior

No variant requirements are available.